Search
for

    Sort by

    Community Join

    180-210 / 1000+ results

      community Shiseido RCH-01

       7 upvotes 7 years ago
      Shiseido RCH-01 and Replicel's upcoming trial data release. Users discuss expected release timelines and clarify quarter dates.

      community How long do you keep ru-58841 on?

      in Product  1 upvotes 6 months ago
      The conversation discusses the application of RU58841 for hair loss, with the user applying 1.75 mg at 5% concentration for half an hour daily. The user mentions managing seborrheic dermatitis while using this treatment.

      community Aiming to Standardize RU58841

      in Chat  7 upvotes 1 year ago
      The conversation discusses the use of RU58841 for hair loss, focusing on its side effects, standardization issues, and user experiences. The user also inquires about the use of other treatments like minoxidil, finasteride, and microneedling.

      community RU58841 and Min - topical 50 mg each day

      in Progress Pictures  6 upvotes 1 year ago
      The conversation is about a person's hair improvement after 14.5 months using RU58841 and Minoxidil topically at 50 mg each day, with noticeable hairline improvement but incomplete crown area recovery. The person struggles to take good pictures of their crown area.

      community 28M. So happy with results so far

      in Progress Pictures  22 upvotes 2 weeks ago
      A 28-year-old male is happy with hair growth results after 7 months on finasteride, taking 0.5mg daily, with no sexual side effects but some mood issues. He considered adding minoxidil but decided to continue only with finasteride due to positive results.

      community Alpha plus from Anagenica - 25%CB???

      in Product  2 upvotes 2 years ago
      A user ordered Alpha Plus from Anagenica, expecting it to contain specific percentages of Fin, Estradiol, Minoxidil, and CB0301. However, the received product's label showed different percentages, including a surprising 25% CB, leading the user to question its safety and accuracy.

      community [M30] Constant swing between continuing or quitting Finasteride

      in General  204 upvotes 8 months ago
      A 30-year-old man is considering quitting Finasteride due to sexual side effects, including reduced libido and difficulty reaching orgasm, despite its effectiveness in treating hair loss. He is exploring other factors like relationship issues and potential low testosterone, and is considering getting blood work done.

      community Ru vendor? Looking for a cheaper source

      in Product  3 upvotes 1 year ago
      The conversation is about finding a cheaper source for RU58841, with a suggestion to use Chemyo. One user suggests that RU58841 may not be necessary.

      community Log #1 - My .25mg EOD Finasteride Journey

      in Finasteride/Dutasteride  6 upvotes 1 year ago
      A user started taking 0.25mg of finasteride every other day to prevent hair loss and documented their experience. Initially, they felt anxious and had headaches, but by the second week, they felt normal with no side effects or changes in hair.

      community M25 - Topical Fin 0.3% Min 6%.

      in Progress Pictures  23 upvotes 7 months ago
      A 25-year-old is using a nightly routine of topical finasteride 0.3% and minoxidil 6%, along with a derma roller and Nizoral shampoo, to address crown hair loss. The user reports no side effects and noticeable improvement over 2.5 months.

      community CB-03-01 supposed hair loss cure

      in Treatment  9 upvotes 5 years ago
      The conversation discusses why CB-03-01, a potential hair loss treatment, isn't widely discussed despite evidence of its effectiveness and safety. Some users mention other treatments like melatonin, procianidin b2, and RU58841, debating their effectiveness and safety.

      community RU58841 from china... Which supplier?

      in Product  6 upvotes 2 years ago
      The conversation is about the quality of RU58841 powder from Shaanxi Laon Biotech. The user is inquiring if anyone has experience with this product.

      community Ru58841 stops seb derm ( the itching)?

      in Treatment  8 upvotes 2 years ago
      RU58841 is discussed as a treatment that stops scalp itching when used with finasteride or dutasteride. The user is considering trying RU58841 due to persistent itching despite using the "big 3" treatments.

      community 42 yo. Fin/Dut for 9 months. Occasional min.

      in Progress Pictures  46 upvotes 4 months ago
      A 42-year-old shares progress using finasteride and dutasteride for 9 months, with occasional minoxidil use, noticing results after a month. The user applied minoxidil consistently for 3 months, then sporadically once a week.

      community 9 month update - 0.25mg finasteride only daily (reposted w updated pics)

      in Progress Pictures  34 upvotes 6 months ago
      A user shared a 9-month update on using 0.25mg finasteride daily for hair maintenance, reporting no significant side effects and considering whether to add other treatments like a dermastamp or ketoconazole. The user has not used minoxidil, believes it's unnecessary unless hair loss is severe, and occasionally takes biotin supplements.

      community Carrier for homemade topical Finasteride

      in Chat  4 upvotes 1 year ago
      The conversation is about making topical finasteride using stemoxydine as a carrier. The user is considering buying Redken Cerafill Hair Re-Densifying Treatment (Stemoxydine) 90ml for this purpose.

      community Almost 11-Months of 1.25mg Fin EOD | 23M

      in Progress Pictures  53 upvotes 6 months ago
      A 23-year-old male shared his 11-month progress using 1.25mg finasteride every other day and Nizoral/Dermazole, reporting reduced hair fall and new hair growth without major shedding. Users discussed the risks of finasteride for younger individuals and suggested consulting a doctor, with some recommending minoxidil as an alternative.

      community PP405 2a study was a safety study. Some rational explaining.

      in Research/Science  22 upvotes 7 months ago
      The conversation discusses the safety study of PP405, emphasizing that early trials focus on safety rather than efficacy, and that any efficacy data from such a short study should be viewed skeptically. It also highlights that the information released is primarily for securing funding, and that meaningful efficacy results are expected in later phases.